BioSpace News Archive

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced it has entered into an arrangement with Clinigen Group plc a global pharmaceutical Services and Products company, to implement a Managed Access Program for lenzilumab.

Surge in bone related problems due to rise in the geriatric population has increased demand for the use of bone stimulators to determine the bone structure and defects associated with it.

The high pressure contrast media injectors market is growing rapidly with an increase in chronic conditions such as neurovascular, cardiovascular, and cancer.

The demand within the global healthcare e-commerce market is growing on back of continuous advancements in the e-commerce industry and online sales of medication.

Endoscopic spinal surgery is a non-invasive procedure to perform complex spinal surgeries with the help of an endoscope.

In a new report by Transparency Market Research, the cell culture market is quickly being embraced in the field of pharmaceuticals.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest survey conducted by Fact.MR, the global arthroscopy products market is poised to reach US$ 6.2 billion in 2021.

The antibody drug conjugates market is anticipated to gain promising growth across the assessment period of 2020-2030 owing to the heightening prevalence of cancer around the world.

Changing lifestyles and the availability of reimbursement policies in the developed countries are also boosting growth opportunities in the wound debridement market.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancers, announced the presentation of additional data from the Phase 3 ADAPT trial of efgartigimod for the treatment of generalized myasthenia gravis.